13F HOLDINGS REPORT
Abingworth LLP
Quarter ended Q1 2023 · Filed February 10, 2023 · Accession 0000950123-23-001542
Total Value
$306.9M
Positions
19
Other Managers
1
Confidential Omitted
No
Holdings (19)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VAXCYTE INC | PCVX | 2,019,057 | $96.8M | 31.54% |
| 2 | VERONA PHARMA PLC | 925050106 | 2,457,500 | $64.2M | 20.92% |
| 3 | VERA THERAPEUTICS INC | VERA | 2,960,231 | $57.3M | 18.66% |
| 4 | HILLEVAX INC | 43157M102 | 1,838,486 | $30.8M | 10.02% |
| 5 | ADICET BIO INC | ACET | 2,115,385 | $18.9M | 6.16% |
| 6 | PHATHOM PHARMACEUTICALS INC | PHAT | 1,435,106 | $16.1M | 5.25% |
| 7 | RENEO PHARMACEUTICALS INC | 75974E103 | 2,073,957 | $4.8M | 1.57% |
| 8 | SIENTRA INC | 82621J105 | 1,673,589 | $3.4M | 1.11% |
| 9 | JASPER THERAPEUTICS INC | JSPRW | 5,628,558 | $2.7M | 0.89% |
| 10 | SOLENO THERAPEUTICS INC | SLNO | 1,201,506 | $2.4M | 0.78% |
| 11 | NUCANA PLC | NCNA | 3,333,333 | $2.2M | 0.72% |
| 12 | EFFECTOR THERAPEUTICS INC | 28202V108 | 4,822,114 | $2.1M | 0.67% |
| 13 | SPRUCE BIOSCIENCES INC | SPRB | 1,792,518 | $2.0M | 0.64% |
| 14 | PARATEK PHARMACEUTICALS INC | 699374302 | 1,041,131 | $1.9M | 0.63% |
| 15 | CYMABAY THERAPEUTICS INC | 23257D103 | 131,036 | $821,596 | 0.27% |
| 16 | EXICURE INC | XCUR | 281,636 | $323,881 | 0.11% |
| 17 | AEGLEA BIOTHERAPEUTICS INC | 00773J103 | 240,500 | $108,225 | 0.04% |
| 18 | MOLECULAR TEMPLATES INC | 608550109 | 200,000 | $66,000 | 0.02% |
| 19 | OBSEVA SA | H5861P103 | 87,999 | $12,760 | 0.00% |